The new era of cervical cancer prevention: The end of the Pap smear?

Diagnostic Cytopathology

Volumn 28, Issue 6, 2003, Pages 289-290

  Davey, Diane D ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE; WART VIRUS VACCINE;

CANCER PREVENTION; CANCER SCREENING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EDITORIAL; FEMALE; HUMAN; MEDICAL TECHNOLOGY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS DETECTION; WART VIRUS;

FEMALE; HUMANS; MASS SCREENING; PATHOLOGY, CLINICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0038312159     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.99998     Document Type: Editorial

References (9)

1. Davey DD, Zarbo RJ. Conference introduction and commentary, strategic science symposium: HPV testing. Are you ready for a new era in cervical cancer screening? Arch Pathol Lab Med 2003 (in press).
2. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
3. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.
4. Kulasingam SI, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-1757.
5. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical cancer screening programs. Arch Pathol Lab Med 2003 (in press).
6. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
7. Clavel C, Masure M, Bory J-P, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7392 women. Br J Cancer 2001;89:1616-1623.
8. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol) 1999;87:48-55.
9. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.